Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 4, 2011, Pages 1155-1159

  Ibrahim, Lobna ^a   Diazgranados, Nancy ^b   Luckenbaugh, David A ^a   Machado Vieira, Rodrigo ^c   Baumann, Jacqueline ^a   Mallinger, Alan G ^a   Zarate, Carlos A ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Depression; Electroconvulsive therapy; Glutamate; NMDA; Treatment resistant

Indexed keywords

KETAMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; EFFECT SIZE; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OUTCOME ASSESSMENT; REACTION TIME; SINGLE DRUG DOSE; SYMPTOMATOLOGY; TREATMENT FAILURE; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; KETAMINE; LINEAR MODELS; MALE; MIDDLE AGED; N-METHYLASPARTATE; PSYCHIATRIC STATUS RATING SCALES; SAMPLE SIZE; SOCIOECONOMIC FACTORS; TREATMENT FAILURE; YOUNG ADULT;

EID: 79955993457     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.03.019     Document Type: Article

References (30)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders IV 1994, American Psychiatric Association, Washington, DC.
2. Bauer M., Pfennig A., Linden M., Smolka M.N., Neu P., Adli M., et al. Efficacy of an algorithm-guided treatment compared with treatment as usual. J Clin Psychopharmacol 2009, 29:327-333.
3. Berman R.M., Cappiello A., Anand A., Oren D.A., Heninger G.R., Charney D.S., et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 2000, 47:351-354.
4. Birkenhager T.K., Broek W.W., Moleman P., Bruijn J.A., et al. Outcome of a 4-step treatment algorithm for depressed inpatients. J Clin Psychiatry 2006, 67:1266-1271.
5. Bremner J.D., Krystal J.H., Putnam F.W., Southwick S.M., Marmar C., Charney D.S., et al. Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS). J Trauma Stress 1998, 11:125-136.
6. Brun V.H., Ytterbo K., Morris R.G., Moser M.B., Moser E.I. Retrograde amnesia for spatial memory induced by NMDA receptor-mediated long-term potentiation. J Neurosci 2001, 21:356-362.
7. Diazgranados N., Ibrahim L., Brutsche N.E., Newberg A., Kronstein P., Khalife S., et al. A randomized add-on trial of an N-methyl-d-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry 2010, 67:793-802.
8. Fava M. Diagnosis and definition of treatment-resistant depression. Biol Psychiatry 2003, 53:649-659.
9. Fink M. The 1990 APA Task Force Report: a quiet revolution. Convuls Ther 1990, 6:75-78.
10. First M.B., Spitzer R.L., Gibbon M., Williams A.R. Structured Clinical Interview for DSM-IV TR Axis I Disorders, research version, patient edition (SCID-I/P) 2001, New York State Psychiatric Institute, Biometrics Research, New York.
11. Husain M.M., Rush A.J., Fink M., Knapp R., Petrides G., Rummans T., et al. Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a consortium for research in ECT (CORE) report. J Clin Psychiatry 2004, 65:485-491.
12. Iodice A.J., McCall W.V. ECT resistance and early relapse: two cases of subsequent response to venlafaxine. J ECT 2003, 19:238-241.
13. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003, 289:3095-3105.
14. Krystal A.D., Weiner R.D., Dean M.D., Lindahl V.H., Tramontozzi L.A., Falcone G., et al. Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT. J Neuropsychiatry Clin Neurosci 2003, 15:27-34.
15. Lamont S.R., Stanwell B.J., Hill R., Reid I.C., Stewart C.A. Ketamine pre-treatment dissociates the effects of electroconvulsive stimulation on mossy fibre sprouting and cellular proliferation in the dentate gyrus. Brain Res 2005, 1053:27-32.
16. Mayberg H.S., Lozano A.M., Voon V., McNeely H.E., Seminowicz D., Hamani C., et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005, 45:651-660.
17. McDaniel W.W., Sahota A.K., Vyas B.V., Laguerta N., Hategan L., Oswald J. Ketamine appears associated with better word recall than etomidate after a course of 6 electroconvulsive therapies. J ECT 2006, 22:103-106.
18. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979, 134:382-389.
19. Okamoto N., Nakai T., Sakamoto K., Nagafusa Y., Higuchi T., Nishikawa T. Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: comparing ketamine and propofol anesthesia. J ECT 2010, 26:223-227.
20. Pagnin D., de Queiroz V., Pini S., Cassano G.B. Efficacy of ECT in depression: a meta-analytic review. J ECT 2004, 20:13-20.
21. Quante A., Zeugmann S., Bajbouj M., Anghelescu I. Clozapine in medication- and electroconvulsive therapy-resistant, depressed inpatients: a case series. J Clin Psychopharmacol 2007, 27:715-717.
22. Rush A.J., Marangell L.B., Sackeim H.A., George M.S., Brannan S.K., Davis S.M., et al. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry 2005, 58:347-354.
23. Rush A.J., Trivedi M.H., Wisniewski S.R., Nierenberg A.A., Stewart J.W., Warden D., et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STARz.ast;D report. Am J Psychiatry 2006, 163:1905-1917.
24. Sackeim H.A. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA 2001, 285:1299-1307.
25. Sackeim H.A. The definition and meaning of treatment-resistant depression. J Clin Psychiatry 2001, 62(Suppl). 16:10-7.
26. Thase M.E., Rush A.J. When at first you don't succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry 1997, 58(Suppl. 13):23-29.
27. The World Health Organization World health report 2001 2000, WHO, Geneva.
28. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 2003, 361:799-808. UK ECT Review Group.
29. Zarate C.A., Rothschild A., Fletcher K.E., Madrid A., Zapatel J. Clinical predictors of acute response with quetiapine in psychotic mood disorders. J Clin Psychiatry 2000, 61:185-189.
30. Zarate C.A., Singh J.B., Carlson P.J., Brutsche N.E., Ameli R., Luckenbaugh D.A., et al. A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 2006, 63:856-864.